The economic impact of captopril after myocardial infarction;DIE WIRTSCHAFTLICHKEIT VON CAPTOPRIL NACH MYOKARDINFARKT

Medizinische Klinik

Volumn 91, Issue 2, 1996, Pages 112-118

  Szucs, Thomas ^a,d   Berger, Karin ^a   Schulte Hillen, Jan ^b   Kleber, Franz X ^c  

^a Forschungsgruppe Med Okonomie   (Germany)

^b Innere Medizin I Kardiologie ^*  (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; PLACEBO;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; GERMANY; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES;

EID: 0030009260     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. AIRE Studie The Acute Infarction Ramipril Efficacy (AIRE) Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 1 (1993), 821-828
2. Ambrosioni, E The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial intarction. New Engl J Med 332 (1995), 80-85
3. AOK-Bundesverbind (Hrsg ) Krankheitsartenstatistik der AOK 1992, Bonn 1995.
4. Beck, J. R., J P. Kassirer, S G Pauker A convenient approximation of life expectancy (The DEALE). Amer J Med 73 (1982), 883-888
5. Bristol-Myers-Squibb Company, 500/600 College Rd East Place, Princeton, 08536 New Jersey.
6. Drummond, M F., G. L Stoddart, G W Torrancc: Methods for the economic evaluation of health care progammes Oxford 1986
7. Gaudron. P , C Eilles, G Ertl. K Kochsiek. Early remodelling of the left ventricle in patients with myocardial infarction Europ Heart J. 11 , Suppl (1990), 139-146
8. Gruppo ltaliano per lo Studio della Supravivenza nell'infarcto Mvocardico. GISSI-3: Effects of lisinopril and transdermal glyceryn trimtrate singly and together on 6-week 343. mortality and ventricular function after myocardial infarction, Lancet 1 (1994), 1115-1112
9. Jeremv, R W , K. C Allmann, G. Bautovic, P J. Harris: Patterns of left ventricular dilatation during six months after myocardial infarction. J Amer. Coll Cardiol. 13 (1989), 304-310
10. Kannel, W. B , F. Sorhe, P. M McNarnara, Prognosis after initial myocardial infarctinon The Framingham Study Amer. J Cardiol 44 (1979), 53-59
11. Klebce, F X , L Niemuller Long-term survivial in the Munich Mild Heart Failure Trial (MHFT) Amer. J. Cardiol 71 (1943), 1237-1239
12. Kleber, F X , L Niemuller, W. Doering; Impact of converting enzyin inhibition or progression of chronic heart failure Results of the Munich Mild Heart Failure Trial (MHFT) Brit Heart J 67 (1992), 289-296
13. Le Pen, C , E Levy. J Bonte: L'analyse cout-efficacitédu treatement par captopril aprés infarcrus du myocarde. Arch Mal Coeur 87 (1994), 775-781
14. Pfeffer, J. M., M A Pfeffer, E Braunwald. influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circulat. Res 57 (1985), 84-95
15. Pfeffer, M A , et al : Effect of captopril on mortality and morbidity in patients with left ventricular dvsfunction after myocardial infarction New Engl J Med 327 (1992), 669-677
16. Pfeffer, M A , G. Lamas, D E Vaughan et al Effect of captopril on progressive ventricular after myocardial infarction New Engl J Med 319 (1989), 304-310.
17. Pfeffer, M A : ACE inhibition in acute myocardial infarction. New Engl J Med, 332 (1995), 118-120.
18. Statistisches Bundesamt (Hrsg). Statistisches Jahrbuch für die Bundesrepublik Deutschlarid. Wiesbaden 1994, 447-478
19. The Multicenter Postinfarction Research Group: Risk stratification and survival after myocardial infarction. New Engl J. Med 309 (1983), 331-336.
20. Weinstein, C M , B. William, B. Stason Foundations of cost-effectiveness analysis for Health and medical practices, New Engl J Med. 31 (1977), 716-721.